AMIODARONE USE IN PATIENTS LISTED FOR HEART TRANSPLANT IS ASSOCIATED WITH INCREASED ONE-YEAR POST-TRANSPLANT MORTALITY

INTRODUCTION: Pre-transplant amiodarone use has been postulated as a risk factor for morbidity and mortality after orthotopic heart transplant (OHT). We assessed pre-OHT amiodarone use and tested the hypothesis that it is associated with impaired post-OHT outcomes. METHODS: We performed a retrospect...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Heart Lung Transplant
Asıl Yazarlar: Cooper, Lauren B., Mentz, Robert J., Edwards, Leah B., Wilk, Amber R., Rogers, Joseph G., Patel, Chetan B., Milano, Carmelo A., Hernandez, Adrian F., Stehlik, Josef, Lund, Lars H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5241253/
https://ncbi.nlm.nih.gov/pubmed/27520780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.healun.2016.07.009
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller